Ultra-Early Screening of Cognitive Decline Due to Alzheimer’s Pathology
Alzheimer’s pathology can be assessed and defined via Aβ and tau biomarkers. The preclinical period of Alzheimer’s disease is long and lasts several decades. Although effective therapies to block pathological processes of Alzheimer’s disease are still lacking, downward trends in the incidence and pr...
| Päätekijä: | |
|---|---|
| Aineistotyyppi: | Artikkeli |
| Kieli: | English |
| Julkaistu: |
MDPI AG
2023-05-01
|
| Sarja: | Biomedicines |
| Aiheet: | |
| Linkit: | https://www.mdpi.com/2227-9059/11/5/1423 |